Literature DB >> 11387158

Breast uptake of iodine-131 mimicking lung metastases in a thyroid cancer patient with a pituitary tumour.

P F Kao1, H Y Chang, M F Tsai, K J Lin, K Y Tzen, C N Chang.   

Abstract

We report a case of a 44-year-old female thyroid cancer patient with a pituitary tumour. 131I whole body scanning showed a change of chest uptake from a unilateral crescent uptake to a bilateral full breast uptake pattern. Hyperprolactinaemia and a pituitary tumour were diagnosed as a result of observing the 131I breast uptake.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11387158     DOI： 10.1259/bjr.74.880.740378

Source DB:  PubMed          Journal:  Br J Radiol        ISSN： 0007-1285            Impact factor:   3.039


  5 in total

1.  Incidental Findings of Intense Radioiodine Uptake in Struma Ovarii and Bilateral Nonlactating Breasts Simultaneously on Postablation 131I SPECT/CT for Papillary Thyroid Cancer.

Authors:  Hye-Kyung Shim; Mi Ra Kim
Journal:  Nucl Med Mol Imaging       Date:  2016-11-11

2.  Bilateral breast uptake of radioiodine in a male patient with gynecomastia: A case report.

Authors:  Lebriz Uslu; Mustafa Ozbayrak; Betul Vatankulu; Kerim Sonmezoglu
Journal:  Indian J Nucl Med       Date:  2015 Oct-Dec

3.  Extremity Radioactive Iodine Uptake on Post-therapeutic Whole Body Scan in Patients with Differentiated Thyroid Cancer.

Authors:  Hiroshi Wakabayashi; Junichi Taki; Anri Inaki; Ayane Toratani; Daiki Kayano; Seigo Kinuya
Journal:  Asia Ocean J Nucl Med Biol       Date:  2015

4.  Tumor necrosis factor-related apoptosis-inducing ligand additive with Iodine-131 of inhibits non-small cell lung cancer cells through promoting apoptosis.

Authors:  Ning Yang; Shuzhan Yao; Dong Liu
Journal:  Oncol Lett       Date:  2018-05-04       Impact factor: 2.967

5.  Bilateral radioiodine uptake by the non-lactating breast of a single nulliparous woman: a case report and literature review.

Authors:  Masoud Moslehi; Majid Assadi
Journal:  Arch Med Sci       Date:  2012-07-04       Impact factor: 3.318
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.